Petros Pharmaceuticals anticipates Drug Facts label technology it’s developing for potential switch of its Stendra ED drug also could be used for other OTC switch proposals. • Source: Petros Pharmaceuticals
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.